Just one obstacle in vaccine improvement is economic: Lots of the illnesses most demanding a vaccine, including HIV, malaria and tuberculosis, exist principally in inadequate international locations. Pharmaceutical corporations and biotechnology businesses have tiny incentive to acquire vaccines